Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
TG1-H5254 | Human | Human TGF-beta RI Protein, Fc Tag (MALS verified) |
|
||
TG1-H5259 | Human | Human TGFR-1 / ALK-5 / TGF-beta receptor type-1 Protein, Llama IgG2b Fc Tag (SPR verified) |
|
Human TGFB1, premium grade (Cat. No. TG1-H4212) immobilized on CM5 Chip can bind Human TGF-beta RI Protein, Fc Tag (Cat. No. TG1-H5254) with an affinity constant of 99.2 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Galunisertib | LY-2157299 | Phase 2 Clinical | Eli Lilly And Company | Breast Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Glioma; Peritoneal Neoplasms; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Prostatic Neoplasms; Solid tumours; Neoplasms; Myelodysplastic Syndromes; Glioblastoma; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Renal Cell; Rectal Neoplasms; Liver Neoplasms | Details |
GF-101 | GFH-018; GF-101; GFH018 | Phase 2 Clinical | Genfleet Therapeutics (Shanghai) Inc | Solid tumours; Liver Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung | Details |
ORG-129 | ORG-129; AGMB-129 | Phase 2 Clinical | Origo Biopharma Sociedad Litmitada | Crohn Disease | Details |
TRK-250 | TRK-250; BNC-1021 | Phase 1 Clinical | Bonac Corp | Idiopathic Pulmonary Fibrosis | Details |
Itacnosertib | TP-0184 | Phase 1 Clinical | Tolero Pharmaceuticals Inc, Sumitomo Dainippon | Solid tumours; Anemia | Details |
Oxinseti | SH-3051 | Phase 1 Clinical | Nanjing Sanhome Pharmaceutical Co Ltd | Solid tumours; Liver Neoplasms | Details |
AGMB-447 | AGMB-447; ORG-447 | Phase 1 Clinical | AgomAb Therapeutics NV | Idiopathic Pulmonary Fibrosis | Details |
TD-1058 | Phase 1 Clinical | Theravance Biopharma Inc | Idiopathic Pulmonary Fibrosis | Details | |
Galunisertib | LY-2157299 | Phase 2 Clinical | Eli Lilly And Company | Breast Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Glioma; Peritoneal Neoplasms; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Prostatic Neoplasms; Solid tumours; Neoplasms; Myelodysplastic Syndromes; Glioblastoma; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Renal Cell; Rectal Neoplasms; Liver Neoplasms | Details |
GF-101 | GFH-018; GF-101; GFH018 | Phase 2 Clinical | Genfleet Therapeutics (Shanghai) Inc | Solid tumours; Liver Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung | Details |
ORG-129 | ORG-129; AGMB-129 | Phase 2 Clinical | Origo Biopharma Sociedad Litmitada | Crohn Disease | Details |
TRK-250 | TRK-250; BNC-1021 | Phase 1 Clinical | Bonac Corp | Idiopathic Pulmonary Fibrosis | Details |
Itacnosertib | TP-0184 | Phase 1 Clinical | Tolero Pharmaceuticals Inc, Sumitomo Dainippon | Solid tumours; Anemia | Details |
Oxinseti | SH-3051 | Phase 1 Clinical | Nanjing Sanhome Pharmaceutical Co Ltd | Solid tumours; Liver Neoplasms | Details |
AGMB-447 | AGMB-447; ORG-447 | Phase 1 Clinical | AgomAb Therapeutics NV | Idiopathic Pulmonary Fibrosis | Details |
TD-1058 | Phase 1 Clinical | Theravance Biopharma Inc | Idiopathic Pulmonary Fibrosis | Details |
This web search service is supported by Google Inc.